Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Chinese EV Contender Xiaomi's Budget 'Tesla Killer' Zooms Past Sales Expectations By 3-5 Times

Published 19/04/2024, 06:46
© Reuters Chinese EV Contender Xiaomi's Budget 'Tesla Killer' Zooms Past Sales Expectations By 3-5 Times

Benzinga - by Anan Ashraf, Benzinga Editor.

The sales of the first electric car by Chinese smartphone manufacturer Xiaomi Corp (OTC:XIACF) have reportedly exceeded expectations by three to five times.

What Happened: Company CEO Lei Jun revealed the unexpected sales figures during a live stream on Douyin, the Chinese equivalent of TikTok, Reuters reported.

The SU7, which was launched last month, has a starting price of 215,900 yuan (about $29,829), lower than even the Tesla Model 3 in China. The pricier variants of the sedan, called Pro and Max, start at 245,900 ($33,973) and 299,900 yuan ($41,434), respectively. Xiaomi received over 50,000 orders in less than half an hour of starting to take orders late last month and has already commenced deliveries of select versions of the vehicle.

In the live stream, the CEO also confirmed that Xiaomi has no plans to build off-road vehicles and will primarily focus on the SU7, Reuters added.

Why It Matters: Since the launch of the SU7, smaller players in China such as Zeekr have slashed prices on their vehicles in an attempt to protect their market share.

"Xiaomi's car officially debuts, the real revolution in smart cars has officially begun, and China will surely give birth to a great company like Tesla," company CEO Lei Jun reportedly said at the delivery ceremony for the founder’s edition of the car earlier this month.

Check out more of Benzinga's Future Of Mobility coverage by following this link.

Read More: Laid Off By Tesla? Here’s What You Get (And Can’t Do) With Their Severance Offer

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Photo via Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.